Posted by Michael Wonder on 10 May 2020
“Don’t back away from cancer drug plan,” Breast Cancer Foundation begs
10 May 2020 - “Don’t use COVID-19 as an excuse to back away from your commitment to cancer patients,” Breast Cancer Foundation NZ begged the Government, in response to today’s announcement of an additional $160 million over four years for PHARMAC to secure the supply of approved medicines.
Evangelia Henderson, chief executive at Breast Cancer Foundation NZ, said, “PHARMAC announced it will continue to take the same approach to approving new drugs that it’s taken for the last 27 years. We all know that’s not good enough for evaluating the latest, specialised cancer drugs. Even the Government acknowledged that last year, when it agreed to develop a plan for early access to new cancer medicines.”
